BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $448,000 | +21.1% | 35,000 | 0.0% | 0.10% | +23.8% |
| Q2 2022 | $370,000 | -35.0% | 35,000 | 0.0% | 0.08% | -28.6% |
| Q1 2022 | $569,000 | +17.3% | 35,000 | 0.0% | 0.11% | +25.8% |
| Q4 2021 | $485,000 | +35.1% | 35,000 | +40.0% | 0.09% | +27.1% |
| Q3 2021 | $359,000 | -54.8% | 25,000 | -50.0% | 0.07% | -56.8% |
| Q2 2021 | $794,000 | +56.0% | 50,000 | 0.0% | 0.16% | +50.0% |
| Q1 2021 | $509,000 | -38.1% | 50,000 | -54.5% | 0.11% | -42.2% |
| Q4 2020 | $822,000 | +8.0% | 110,010 | -50.4% | 0.19% | +6.9% |
| Q3 2020 | $761,000 | -14.1% | 221,629 | +19.2% | 0.18% | +4.2% |
| Q2 2020 | $886,000 | – | 185,929 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |